Scythian Chief Medical Officer Professor Michael Barnes Expands Global Influence as a Cannabis Key Opinion Leader
25 juil. 2018 08h34 HE
|
Scythian Biosciences Corp.
TORONTO, July 25, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF)...
Scythian Biosciences Corp. Announces Strategic Partnership for Cannabis in Brazil with one of the Founders of the Country’s Pharma Industry
23 juil. 2018 08h34 HE
|
Scythian Biosciences Corp.
TORONTO, July 23, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC – Nasdaq...
Scythian Announces Strategic Sale of Latin American and Caribbean Assets in $193,000,000 Deal to Aphria
17 juil. 2018 08h34 HE
|
Scythian Biosciences Corp.
Sale of Assets Transforms Scythian Into a Highly Liquid and Well Capitalized Company with Over $200 million in Cash and Marketable Securities on Hand Allows for Additional Transactions in Line with...
Scythian Biosciences Announces Positive Pre-Clinical Data on the Safety and Efficacy of Cannabis Derived Combination Therapy for Mild to Moderate Traumatic Brain Injury
13 juil. 2018 17h05 HE
|
Scythian Biosciences Corp.
TORONTO, July 13, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) and its partners at the University of Miami...
Scythian Biosciences Corp Announces Colcanna SAS as one of the Industry’s First to Receive Key Cannabis Licences for the Cultivation, Extraction, Production and Research of Medical Cannabis for the Colombian Local Market and Export to International Markets
09 juil. 2018 08h30 HE
|
Scythian Biosciences Corp.
TORONTO, July 09, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Colombian-based...
Scythian Biosciences Announces Name Change to SOL Global Investments Corp.
05 juin 2018 08h58 HE
|
Scythian Biosciences Corp.
TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company will...
Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia
16 mai 2018 09h14 HE
|
Scythian Biosciences Corp.
– ENTERS INTO EXCLUSIVE SUPPLY AGREEMENT WITH APHRIA – – COLCANNA TO BE FIRST TO MARKET WITH APHRIA’S PHARMACEUTICAL GRADE CBD OIL IN COLOMBIA – TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Scythian...
Scythian Biosciences Announces Binding Agreement for Argentinian Acquisition of ABP
11 mai 2018 08h30 HE
|
Scythian Biosciences Corp.
– ABP HOLDS FIRST & ONLY CANNABIS LICENSE IN ARGENTINA – – ABP REVENUES IN EXCESS OF USD$11 MILLION IN 2017 AND PROFITABLE – TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences...
Scythian Biosciences Announces Licensing Agreement With Isodiol International Inc.
07 mai 2018 08h30 HE
|
Scythian Biosciences Corp.
— Scythian Makes $2 Million Investment Alongside Serruya Private Equity, and the Delavaco Group — — Isodiol Recently Awarded the Highly Coveted UK Government Approval for Natural CBD Isolate as an...
Scythian Announces Marigold’s Exclusive Agreement with Jamaica’s Peter Tosh Museum
03 mai 2018 08h30 HE
|
Scythian Biosciences Corp.
— Medicinal Cannabis Dispensary to open in Peter Tosh Square — — Peter Tosh Square to be the home of Marigold’s first herb house — TORONTO, May 03, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences...